Suggestions for Radiation Oncologists during the COVID-19 Pandemic

SARS-CoV-2 pandemic and COVID-19 diffusion have recently become an international public health emergency. Cancer patients, as a frail population, are particularly exposed to the risk related to infections. The clinical decision-making process and the organizational workflow of radiotherapy department should be revised in the light of the critical situation. We herein provide practical suggestions derived from the available literature and discussed during an online session held within the e-learning educational program of the European School of Oncology on March 31st 2020

Fibrosarcome du larynx - A propos d'un cas

Le fibrosarcome du larynx est une entité histologique rare, qui représente moins de 10% de tous les sarcomes des tissus mous, moins de 2 % des cancers laryngés. Cette localisation pose des problèmes diagnostique, thérapeutique et pronostique. Nous présentons un cas de fibrosarcome laryngé chez un patient de 54 ans. La confirmation histologique etimmunohistologique a été faite sur la pièce d’exérèse chirurgicale et surtout sur une confrontation anatomoclinique. La prise en charge thérapeutique est multidisciplinaire, associant la chirurgie qui doit être la plus complète sans curage ganglionnaire et la radiothérapie. Le pronostic est généralement sévère, dépend essentiellement de degré de différenciation histologique.Mots clés : fibrosarcome ; larynx ; chirurgie ; radiothérapie

Suggestions for Radiation Oncologists during the COVID-19 Pandemic

SARS-CoV-2 pandemic and COVID-19 diffusion have recently become an international public health emergency. Cancer patients, as a frail population, are particularly exposed to the risk related to infections. The clinical decision-making process and the organizational workflow of radiotherapy department should be revised in the light of the critical situation. We herein provide practical suggestions derived from the available literature and discussed during an online session held within the e-learning educational program of the European School of Oncology on March 31st 2020

Carcinome a petites cellules du sinus piriforme : a propos d’une observation.

Les auteurs rapportent un cas de localisation au sinus piriforme d’un carcinome à petites cellules. Ce type histologique a été souvent décrit dans la pathologie tumorale pulmonaire. Sa localisation au sinus piriforme étant exceptionnelle. Nous présentons dans ce document les aspects endoscopiques, radiologiques, anatomopathologiques et thérapeutiques de cette tumeur qui a été diagnostiquée chez un patient de 56 ans.Mots-clés : Sinus piriforme, carcinome à petites cellules, endoscopie, radiologie, anatomopathologie, traitement

The current status of National Cancer Control Plans in Africa: Data from 32 countries

Background: Cancer incidence and mortality are rapidly rising in Africa. National Cancer Control Plans (NCCPs have contributed to a reduction in the burden of some preventable cancers, availing early diagnosis and adequate treatment modalities and palliative care, while sustaining them with sufficient monitoring systems. knowledge we undertook a cross-sectional survey across continental Africa to understand the presence of NCCPs, availability of early detection and screening policies and the status of health financing pertaining to cancer. Methods: Through an online survey, we approached key cancer care staff in 54 countries. Questions were themed in 3 main areas - Cancer registries and national cancer control plans (NCCPs) availability in countries, Cancer screening, diagnosis and management capacity, Financing in cancer care. Results: On 54 approached respondents, we received 32 responses. 88 % of responding countries have active national cancer registries, 75 % with NCCPs and 47 % with cancer screening policies and practices. Universal Health Coverage is available in 40 % of countries. Conclusion: Our study shows that there is a scarcity of NCCPs in Africa. Deliberate investment in cancer registry and clinical services is key to improving access to care and ultimately reduce cancer mortality in Afric

Angiomyxome agressif de la joue : a propos d’une observation

L’angiomyxome agressif est une tumeur mésenchymateuse développée aux dépens du tissu conjonctif avec un site de prédilection pour les parties molles du périné féminin. Cette tumeur croit progressivement mais n’est pas métastatique. Le traitement indiqué actuellement est l’exérèse chirurgicale large sans conséquences fonctionnelles lourdes. La tumeur a une tendance à la récidive locale, qui est fréquente, liée à la difficulté d’une exérèse initiale complète. Les auteurs rapportent ici le cas d’un angiomyxome agressif de la joue, qui a été traité par chirurgie et chimiothérapie. Les aspects cliniques, histologiques et thérapeutiques de la tumeur ont été discutés.Mots-clés : L’angiomyxome agressif, tumeur mésenchymateuse, exérèse, récidive

Production of recombinant proteins GST L1, E6 and E7 tag HPV 16 for antibody detection of Tunisian cervical cancer patients

In the present work recombinant proteins were produced for used in LUMINEX in order to undergo serological study of Tunisian female population. HPV types 16 L1, E6 and E7 sequences fused to their3’-end to a sequence encoding the terminal undecapeptide of the SV40 large T-antigen (tag) were isolated from plasmids and inserted into a pGEX vector for expression as GST fusion proteins in Escherichia coli. Coding sequences for L1tag, E6tag and E7tag of HPV 16 respectively were mobilized by digestion with enzymes and ligated into digested plasmids downstream of the GST domain. An expression plasmid for GST tag was constructed by inserting a fragment coding for the tag epitope. Data showed that the lysates were stable for detection and they were used in Luminex for detection of antibodies in female Tunisian female patients. This assay showed that the sero-positivity towards thedifferent antigens depends upon the group studied and differences between cases and controls were significant (